Streetbeat News

Earnings

HSIC

SAGE

SQNS

TIVC

TRHC

VTGN

YELL

U.S. stocks were higher with the Dow Jones gaining over 300 points. Henry Schein Inc reported better-than-expected Q2 earnings with sales of $3.10 billion, slightly missing the consensus of $3.11 billion. Vistagen Therapeutics, Tabula Rasa HealthCare, and Sequans Communications saw their shares rise after positive news. Sage Therapeutics, Tivic Health Systems, and Yellow Corporation saw their shares drop due to negative developments.

Portfolio Pulse from Lisa Levin

August 07, 2023 | 4:01 pm

CEIX

CONSOL Energy (NYSE:CEIX) is set to release its latest quarterly earnings report on Tuesday, 2023-08-08. Analysts estimate an earnings per share (EPS) of $4.43. The company's past performance shows a trend of beating EPS estimates but also a drop in share price following the earnings release. The stock is currently trading at $71.63 and has seen a 12.71% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 4:01 pm

J

Jacobs Solutions (NYSE:J) is set to release its quarterly earnings report on Tuesday, 2023-08-08. Analysts estimate an EPS of $1.84. The company's past performance shows a mixed impact on the share price post-earnings release. The stock is currently trading at $127.23 and has seen a 3.44% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 4:01 pm

PLTK

Playtika Holding (NASDAQ:PLTK) is set to release its latest quarterly earnings report on August 8, 2023. Analysts estimate an earnings per share (EPS) of $0.21. The company's past performance shows a trend of beating EPS estimates, which has generally led to an increase in share price. However, the stock has been down 4.45% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 4:01 pm

HR

Healthcare Realty Trust (NYSE:HR) is set to release its latest quarterly earnings report on Tuesday, 2023-08-08, with analysts estimating an earnings per share (EPS) of $0.40. The company's stock performance has been generally negative over the last 52-week period, with shares down 23.31%. Investors will be looking for not only an earnings beat but also positive guidance for the next quarter.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 4:01 pm

PET

Wag Group (NASDAQ:PET) is set to release its latest quarterly earnings report on Tuesday, 2023-08-08. Analysts estimate an earnings per share (EPS) of $-0.09. The company's past performance shows a mixed trend of beating and missing EPS estimates, with corresponding changes in share price. The stock is currently trading at $2.35, down 71.59% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 4:01 pm

NPO

EnPro Indus (NYSE:NPO) is set to release its latest quarterly earnings report on August 8, 2023. Analysts estimate an earnings per share (EPS) of $1.73. The company's past performance shows a trend of beating EPS estimates, which has generally led to an increase in share price. The stock is currently trading at $136.85, up 40.75% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 4:01 pm

BYND

Beyond Meat Inc (NASDAQ:BYND) is expected to report a Q2 loss of 81 cents per share on revenue of $111.28 million. The company has beaten estimates in the last two quarters after missing estimates in five straight prior quarters. Beyond Meat shares are down 7.50% ahead of the company's quarterly results. The company also provided full-year guidance, expecting revenues to be in the range of $375 million to $415 million.

Portfolio Pulse from Adam Eckert

August 07, 2023 | 3:54 pm

AAPL

AMZN

The S&P 500 Index experienced significant volatility last week, largely due to earnings reports from Apple and Amazon, and mixed job market numbers. The use of leverage in trading, particularly options, has increased post-2008, affecting market price action. Market makers, who provide liquidity and ensure no major disruptions, play a crucial role in this. The article also discusses the impact of options key price levels on the S&P 500 Index and suggests a bearish outlook for the coming week.

Portfolio Pulse from Menthor Q Research

August 07, 2023 | 3:52 pm

VTRS

Viatris Inc reported Q2 FY23 sales of $3.91 billion, up 2% on a divestiture-adjusted operational basis, slightly higher than the consensus of $3.89 billion. The company generated approximately $124 million in new product revenues in Q2, primarily driven by lenalidomide in the U.S. It reported an adjusted EPS of $0.75, better than the consensus of $0.71. The FDA accepted for review Viatris and Mapi Pharma's New Drug Application for GA Depot 40 mg, a therapy for multiple sclerosis. VTRS shares are up 7.32%.

Portfolio Pulse from Vandana Singh

August 07, 2023 | 3:36 pm